LEO Pharma Initiates Phase 2a Trial of Delgocitinib Cream in Adults With PPP
LEO Pharma is initiating a Phase 2a proof-of-concept trial to evaluate the efficacy and safety of delgocitinib cream in the treatment of adults with mild-to-severe Palmoplantar Pustulosis (PPP).